Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-07-02T17:05:27.347Z Has data issue: false hasContentIssue false

Chapter 8 - A Phenomenology-Based Approach to Inborn Errors of Metabolism with Dystonia

from Section I - General Principles and a Phenomenology-Based Approach to Movement Disorders and Inherited Metabolic Disorders

Published online by Cambridge University Press:  24 September 2020

By
Hendriekje Eggink ,
Anouk Kuiper ,
Tom J. de Koning ,
Martje E. van Egmond  and
Marina A. J. Tijssen
Edited by
Darius Ebrahimi-Fakhari  and
Phillip L. Pearl
Darius Ebrahimi-Fakhari
Affiliation:
Harvard Medical School
Phillip L. Pearl
Affiliation:
Harvard Medical School
Get access

Summary

Historically, childhood-onset, isolated, generalized, and inherited forms of dystonia (such as DYT1 dystonia) and adult-onset, isolated, focal, mainly idiopathic dystonias have been emphasized. There is, however, growing awareness of neurometabolic disorders being etiological for both childhood-onset and adult-onset dystonia. The dystonia syndromes associated with inborn errors of metabolism (IEMs) usually have an early and (sub-) acute onset, progressive course, and generalized distribution [1]. In general, patients with an IEM do not present with isolated dystonia, but have additional neurological and non-neurological symptoms. This combined or mixed presentation of dystonia and other symptoms may suggest an IEM as the underlying cause. Recognition of dystonia as a clinical feature of a given IEM is essential for diagnostic and targeted treatment strategies, because IEMs include a group of treatable disorders. In addition, symptomatic treatment of dystonia is important as movement disorders negatively impact on the quality of life and daily functioning in patients with an IEM [2].

Type
Chapter
Information
Movement Disorders and Inherited Metabolic Disorders
Recognition, Understanding, Improving Outcomes
 , pp. 111 - 123
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Garcia-Cazorla, A, Wolf, NI, Serrano, M, et al. Inborn errors of metabolism and motor disturbances in children. J Inherit Metab Dis. 2009;32(5):618–29.Google Scholar
Eggink, H, Kuiper, A, Peall, KJ, et al. Rare inborn errors of metabolism with movement disorders: A case study to evaluate the impact upon quality of life and adaptive functioning. Orphanet J Rare Dis. 2014;9:177.Google Scholar
Albanese, A, Bhatia, K, Bressman, SB, et al. Phenomenology and classification of dystonia: A consensus update. Mov Disord. 2013;28(7):863–73.CrossRefGoogle ScholarPubMed
Lehericy, S, Tijssen, MA, Vidailhet, M, Kaji, R, Meunier, S. The anatomical basis of dystonia: Current view using neuroimaging. Mov Disord. 2013;28(7):944–57.Google Scholar
Steeves, TD, Day, L, Dykeman, J, Jette, N, Pringsheim, T. The prevalence of primary dystonia: A systematic review and meta-analysis. Mov Disord. 2012;27(14):1789–96.Google Scholar
Gouider-Khouja, N, Kraoua, I, Benrhouma, H, Fraj, N, Rouissi, A. Movement disorders in neuro-metabolic diseases. Eur J Paediatr Neurol. 2010;14(4):304–7.CrossRefGoogle ScholarPubMed
Fung, VS, Jinnah, HA, Bhatia, K, Vidailhet, M. Assessment of patients with isolated or combined dystonia: An update on dystonia syndromes. Mov Disord. 2013;28(7):889–98.Google Scholar
van Egmond, ME, Kuiper, A, Eggink, H, et al. Dystonia in children and adolescents: A systematic review and a new diagnostic algorithm. J Neurol Neurosurg Psychiatry. 2015;86(7):774–81.Google Scholar
Kuiper, MJ, Brandsma, R, Vrijenhoek, L, et al. Physiological movement disorder-like features during typical motor development. Eur J Paediatr Neurol. 2018;22(4):595–601.CrossRefGoogle ScholarPubMed
Rosenbaum, P, Paneth, N, Leviton, A, et al. A report: The definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109:8–14.Google Scholar
Bax, M, Tydeman, C, Flodmark, O. Clinical and MRI correlates of cerebral palsy: The European Cerebral Palsy Study. JAMA. 2006;296(13):1602–8.Google Scholar
Schneider, SA, Bhatia, KP. Secondary dystonia: Clinical clues and syndromic associations. Eur J Neurol. 2010;17 Suppl 1:52–7.CrossRefGoogle ScholarPubMed
Kuiper, A, Eggink, H, Tijssen, MA, de Koning, TJ. Neurometabolic disorders are treatable causes of dystonia. Rev Neurol (Paris). 2016;172(8–9):455–64.CrossRefGoogle ScholarPubMed
van Egmond, ME, Eggink, H, Kuiper, A, et al. Crossing barriers: A multidisciplinary approach to children and adults with young-onset movement disorders. J Clin Mov Disord. 2018;5:3.CrossRefGoogle ScholarPubMed
Maas, R, Wassenberg, T, Lin, JP, van de Warrenburg, BPC, Willemsen, M. L-dopa in dystonia: A modern perspective. Neurology. 2017;88(19):1865–71.Google Scholar
Koy, A, Lin, JP, Sanger, TD, et al. Advances in management of movement disorders in children. Lancet Neurol. 2016;15(7):719–35.Google Scholar
van Egmond, ME, Lugtenberg, CHA, Brouwer, OF, et al. A post hoc study on gene panel analysis for the diagnosis of dystonia. Mov Disord. 2017;32(4):569–75.Google Scholar
Hennekam, RC, Biesecker, LG. Next-generation sequencing demands next-generation phenotyping. Hum Mutat. 2012;33(5):884–6.CrossRefGoogle ScholarPubMed
Ng, J, Papandreou, A, Heales, SJ, Kurian, MA. Monoamine neurotransmitter disorders: Clinical advances and future perspectives. Nat Rev Neurol. 2015;11(10):567–84.Google Scholar
Lee, WW, Jeon, BS. Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep. 2014;14(7):461.Google Scholar
Taly, AB, Meenakshi-Sundaram, S, Sinha, S, Swamy, HS, Arunodaya, GR. Wilson disease: Description of 282 patients evaluated over 3 decades. Medicine (Baltimore). 2007;86(2):112–21.CrossRefGoogle ScholarPubMed
Stamelou, M, Tuschl, K, Chong, WK, et al. Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: A new treatable disorder. Mov Disord. 2012;27(10):1317–22.Google Scholar
Schneider, SA, Bhatia, KP. Rare causes of dystonia parkinsonism. Curr Neurol Neurosci Rep. 2010;10(6):431–9.Google Scholar
Viau, K, Ernst, SL, Vanzo, RJ, et al. Glutaric acidemia type 1: Outcomes before and after expanded newborn screening. Mol Genet Metab. 2012;106(4):430–8.CrossRefGoogle ScholarPubMed
Dionisi-Vici, C, Deodato, F, Roschinger, W, Rhead, W, Wilcken, B. ‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long-term outcome and effects of expanded newborn screening using tandem mass spectrometry. J Inherit Metab Dis. 2006;29(2–3):383–9.Google Scholar
Koens, LH, Kuiper, A, Coenen, MA, et al. Ataxia, dystonia and myoclonus in adult patients with Niemann–Pick type C. Orphanet J Rare Dis. 2016;11:121.Google Scholar
Patterson, MC, Hendriksz, CJ, Walterfang, M, et al. Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update. Mol Genet Metab. 2012;106(3):330–44.CrossRefGoogle ScholarPubMed
Roze, E, Paschke, E, Lopez, N, et al. Dystonia and parkinsonism in GM1 type 3 gangliosidosis. Mov Disord. 2005;20(10):1366–9.Google Scholar
Gautschi, M, Merlini, L, Calza, AM, et al. Late diagnosis of fucosidosis in a child with progressive fixed dystonia, bilateral pallidal lesions and red spots on the skin. Eur J Paediatr Neurol. 2014;18(4):516–9.Google Scholar
Martikainen, MH, Ng, YS, Gorman, GS, et al. Clinical, genetic, and radiological features of extrapyramidal movement disorders in mitochondrial disease. JAMA Neurol. 2016;73(6):668–74.Google Scholar
Rahman, S, Thorburn, D. Nuclear gene-encoded Leigh syndrome overview. GeneReviews®. 2015; Oct 1.Google Scholar
Ortigoza-Escobar, JD, Molero-Luis, M, Arias, A, et al. Free-thiamine is a potential biomarker of thiamine transporter-2 deficiency: A treatable cause of Leigh syndrome. Brain. 2016;139(Pt 1):31–8.CrossRefGoogle ScholarPubMed
Synofzik, M, Srulijes, K, Godau, J, Berg, D, Schols, L. Characterizing POLG ataxia: Clinics, electrophysiology and imaging. Cerebellum. 2012;11(4):1002–11.CrossRefGoogle ScholarPubMed
Barnerias, C, Saudubray, JM, Touati, G, et al. Pyruvate dehydrogenase complex deficiency: Four neurological phenotypes with differing pathogenesis. Dev Med Child Neurol. 2010;52(2):e1–9.Google Scholar
Pearson, TS, Akman, C, Hinton, VJ, Engelstad, K, De Vivo, DC. Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS). Curr Neurol Neurosci Rep. 2013;13(4):342.CrossRefGoogle ScholarPubMed
van de Kamp, JM, Mancini, GM, Salomons, GS. X-linked creatine transporter deficiency: Clinical aspects and pathophysiology. J Inherit Metab Dis. 2014;37(5):715–33.CrossRefGoogle ScholarPubMed
Lagarde, J, Roze, E, Apartis, E, Pothalil, D, Sedel, F, Couvert, P, et al. Myoclonus and dystonia in cerebrotendinous xanthomatosis. Mov Disord. 2012;27(14):1805–10.Google Scholar
Rubio-Agusti, I, Carecchio, M, Bhatia, KP, et al. Movement disorders in adult patients with classical galactosemia. Mov Disord. 2013;28(6):804–10.CrossRefGoogle ScholarPubMed
Peall, KJ, Kuiper, A, de Koning, TJ, Tijssen, MA. Non-motor symptoms in genetically defined dystonia: Homogenous groups require systematic assessment. Parkinsonism Relat Disord. 2015;21(9):1031–40.Google Scholar
Timmers, ER, Kuiper, A, Smit, M, et al. Non-motor symptoms and quality of life in dopa-responsive dystonia patients. Parkinsonism Relat Disord. 2017;45:57–62.Google Scholar
Balash, Y, Giladi, N. Efficacy of pharmacological treatment of dystonia: Evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options. Eur J Neurol. 2004;11(6):361–70.Google Scholar
Liow, NY, Gimeno, H, Lumsden, DE, et al. Gabapentin can significantly improve dystonia severity and quality of life in children. Eur J Paediatr Neurol. 2016;20(1):100–7.Google Scholar
Sayer, C, Lumsden, DE, Kaminska, M, Lin, JP. Clonidine use in the outpatient management of severe secondary dystonia. Eur J Paediatr Neurol. 2017;21(4):621–6.Google Scholar
Mink, JW. Treatment of paroxysmal dyskinesias in children. Curr Treat Options Neurol. 2015;17(6):350.CrossRefGoogle ScholarPubMed
Jankovic, J. Medical treatment of dystonia. Mov Disord. 2013;28(7):1001–12.Google Scholar
Jinnah, HA, Alterman, R, Klein, C, et al. Deep brain stimulation for dystonia: A novel perspective on the value of genetic testing. J Neural Transm (Vienna). 2017;124(4):417–30.Google Scholar
Ge, M, Zhang, K, Ma, Y, et al. Bilateral subthalamic nucleus stimulation in the treatment of neurodegeneration with brain iron accumulation type 1. Stereotact Funct Neurosurg. 2011;89(3):162–6.CrossRefGoogle ScholarPubMed
Lumsden, DE, Gimeno, H, Tustin, K, Kaminska, M, Lin, JP. Interventional studies in childhood dystonia do not address the concerns of children and their carers. Eur J Paediatr Neurol. 2015;19(3):327–36.CrossRefGoogle Scholar
Lumsden, DE, Allen, NM. Rethinking status dystonicus: A welcome start to a challenging problem. Mov Disord. 2018;33(2):344.Google Scholar
Lumsden, DE, King, MD, Allen, NM. Status dystonicus in childhood. Curr Opin Pediatr. 2017;29(6):674–82.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×